25.36
price up icon0.88%   0.22
after-market 시간 외 거래: 25.36
loading

Pfizer Inc 주식(PFE)의 최신 뉴스

pulisher
Jul 23, 2025

Global Dysmenorrhea Treatment Market to Cross ~USD 8 Billion by 2032 | DelveInsight - GlobeNewswire Inc.

Jul 23, 2025
pulisher
Jul 23, 2025

Here's What to Expect From Pfizer's Non-Oncology Drugs in Q2 Earnings - The Globe and Mail

Jul 23, 2025
pulisher
Jul 23, 2025

Ex-Dividend Reminder: GE HealthCare Technologies, Pfizer and Old Second Bancorp - Nasdaq

Jul 23, 2025
pulisher
Jul 23, 2025

Pfizer Nears Major Bottom: A Turning Point for Investors? - FXEmpire

Jul 23, 2025
pulisher
Jul 23, 2025

Pfizer: Building The Next Oncology Empire - Seeking Alpha

Jul 23, 2025
pulisher
Jul 22, 2025

Why Regency Centers, Tyson Foods, And Pfizer Are Winners For Passive Income - Yahoo Finance

Jul 22, 2025
pulisher
Jul 22, 2025

Here's What To Expect From Pfizer's Non-Oncology Drugs In Q2 Earnings - Barchart.com

Jul 22, 2025
pulisher
Jul 22, 2025

Pfizer Stock (PFE) Opinions on Stagnant Performance and Policy Risks - Quiver Quantitative

Jul 22, 2025
pulisher
Jul 22, 2025

Is Pfizer Inc. a good long term investmentRecord-setting profit potential - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Pfizer Inc. stockBreakthrough profits - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Pfizer Inc. (NYSE:PFE) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed? - Yahoo Finance

Jul 22, 2025
pulisher
Jul 22, 2025

Chinese Biotechs Sweep ADC Plus PD-(L)1/VEGF Bispecific Combos Into Phase II - insights.citeline.com

Jul 22, 2025
pulisher
Jul 22, 2025

Request for Proposals: Pfizer Independent Medical Education Grant Program - fundsforNGOs

Jul 22, 2025
pulisher
Jul 21, 2025

Lobbying Update: $3,490,000 of PFIZER INC. lobbying was just disclosed - Quiver Quantitative

Jul 21, 2025
pulisher
Jul 21, 2025

Sickle Cell Disease Market Set to Grow Substantially Through 2034, DelveInsight Projects | Sanofi, CSL Behring, ITB-Med LLC, Novo Nordisk A/S, Fortrea, Inc., Novartis, Afimmune, Pfizer, ADDMEDICA SASA - The Globe and Mail

Jul 21, 2025
pulisher
Jul 20, 2025

Should You Forget Pfizer and Buy This Magnificent Dividend Stock Instead? - AOL.com

Jul 20, 2025
pulisher
Jul 20, 2025

What drives Pfizer Inc. stock priceFree Stock Market Return Analysis - Jammu Links News

Jul 20, 2025
pulisher
Jul 20, 2025

Pfizer Inc. Stock Analysis and ForecastOutstanding stock performance - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 19, 2025

Can Pfizer Limited (PFIZER) Maintain Its ValuationFree Market Volatility Navigation Tips - Jammu Links News

Jul 19, 2025
pulisher
Jul 19, 2025

Pfizer’s Discounted Stock Offers Yield, But Risks Linger - Finimize

Jul 19, 2025
pulisher
Jul 19, 2025

Sally Susman helped steer Pfizer through COVID-19. Her advice for leaders? Learn to write — and listen. - Business Insider

Jul 19, 2025
pulisher
Jul 19, 2025

Pfizer Inc. - Britannica

Jul 19, 2025
pulisher
Jul 18, 2025

Pfizer’s (PFE) Dividend Safety: Balancing Innovation and Shareholder Returns - Yahoo Finance

Jul 18, 2025
pulisher
Jul 18, 2025

Pharma 50: The top pharma companies in the world for 2025 - drugdiscoverytrends.com

Jul 18, 2025
pulisher
Jul 18, 2025

Morgan Stanley Maintains a Hold on Pfizer (PFE) - MSN

Jul 18, 2025
pulisher
Jul 18, 2025

Pfizer (PFE) and Bristol Myers (BMY) Launch Direct-to-Patient Eliquis Program - MSN

Jul 18, 2025
pulisher
Jul 18, 2025

Pfizer’s Hemophilia Study: Insights into Treatment Patterns and Outcomes - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Pfizer’s BeneFIX Study Update: Key Insights for Investors - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Pfizer’s Phase 3 RSV Vaccine Study: A Potential Game-Changer in Maternal Health - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Pfizer’s Lyme Disease Vaccine Study: Key Insights for Investors - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Pfizer’s Promising Phase 2 Study on Inotuzumab Ozogamicin for Pediatric Leukemia - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Pfizer’s Rimegepant Study: A New Hope for Migraine Sufferers - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Pfizer’s Rimegepant Study: A New Hope for Migraine Prevention? - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Pfizer’s ABRYSVO Vaccine Study: A Potential Game-Changer in Infant RSV Prevention - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Pfizer's Global Health Fellows Program: Leveraging Colleagues’ Expertise to Help Improve Healthcare Access Around the World - Pfizer

Jul 18, 2025
pulisher
Jul 18, 2025

Pfizer’s Latest Study on PF-07799544: A Potential Game-Changer for Advanced Solid Tumors - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Rx Rundown: Sarep­ta Ther­a­peu­tics, Juul, Pfizer and more - Medical Marketing and Media

Jul 18, 2025
pulisher
Jul 18, 2025

BMS, Pfizer take DTC route for blood thinner Eliquis - pharmaphorum

Jul 18, 2025
pulisher
Jul 18, 2025

13 Cheap Stocks Under $50 to Buy Now - Insider Monkey

Jul 18, 2025
pulisher
Jul 17, 2025

Pfizer, Lilly spend big on telehealth contracts: Lawmaker report - Sherwood News

Jul 17, 2025
pulisher
Jul 17, 2025

Bristol Myers, Pfizer to sell blood thinner Eliquis directly to US patients - Reuters

Jul 17, 2025
pulisher
Jul 17, 2025

BMS/Pfizer To Sell Discounted Eliquis Direct – And Other Drugmakers May Follow Suit - insights.citeline.com

Jul 17, 2025
pulisher
Jul 17, 2025

Pfizer Just Reversed Its Bull Run. Is It A Buy Or A Sell? - Investor's Business Daily

Jul 17, 2025
pulisher
Jul 17, 2025

Bristol‑Myers Squibb, Pfizer Set To Launch Direct‑To‑Patient Eliquis At 40% Off - Benzinga

Jul 17, 2025
pulisher
Jul 17, 2025

Pfizer (PFE) Expands Patient Access With Eliquis (Apixaban) Direct Purchase Program - simplywall.st

Jul 17, 2025
pulisher
Jul 17, 2025

Pfizer’s EPIC-Peds Study: A Potential Game-Changer for Pediatric COVID-19 Treatment - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Pfizer’s Phase 1 Study on PF-07941944: Key Insights for Investors - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Pfizer’s Pediatric Leukemia Study: Implications for BESPONSA’s Market Potential - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Bristol Myers, Pfizer to offer Eliquis at a discount for some patients - BioPharma Dive

Jul 17, 2025
$113.56
price up icon 3.08%
drug_manufacturers_general SNY
$50.16
price up icon 2.89%
$309.22
price up icon 1.15%
drug_manufacturers_general MRK
$83.98
price up icon 2.90%
drug_manufacturers_general NVO
$70.03
price up icon 4.87%
자본화:     |  볼륨(24시간):